Compare Stocks: ZYXI, HSCS, ICU, and FEMY

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEMY Femasys	$1.50	$2.40	$1.46 ▼ $22.20	$12.57M	-2.16	110,098 shs	126,109 shs
HSCS HeartSciences	$3.14	$3.53	$1.63 ▼ $5.25	$15.61M	1.76	231,853 shs	21,844 shs
ICU SeaStar Medical	$2.41	$3.28	$2.07 ▼ $6.48	$10.63M	-1.09	267,443 shs	340,180 shs
ZYXI Zynex	$0.13	$0.12	$0.12 ▼ $2.82	$3.80M	0.99	2.32 million shs	N/A

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEMY Femasys	0.00%	-9.09%	-39.52%	-50.98%	-88.16%
HSCS HeartSciences	0.00%	+3.97%	-33.62%	+24.11%	-4.56%
ICU SeaStar Medical	0.00%	-16.90%	-29.53%	-32.49%	-60.74%
ZYXI Zynex	0.00%	0.00%	0.00%	0.00%	-91.07%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEMY Femasys	$1.50	$2.40	$1.46 ▼ $22.20	$12.57M	-2.16	110,098 shs	126,109 shs
HSCS HeartSciences	$3.14	$3.53	$1.63 ▼ $5.25	$15.61M	1.76	231,853 shs	21,844 shs
ICU SeaStar Medical	$2.41	$3.28	$2.07 ▼ $6.48	$10.63M	-1.09	267,443 shs	340,180 shs
ZYXI Zynex	$0.13	$0.12	$0.12 ▼ $2.82	$3.80M	0.99	2.32 million shs	N/A

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEMY Femasys	0.00%	-9.09%	-39.52%	-50.98%	-88.16%
HSCS HeartSciences	0.00%	+3.97%	-33.62%	+24.11%	-4.56%
ICU SeaStar Medical	0.00%	-16.90%	-29.53%	-32.49%	-60.74%
ZYXI Zynex	0.00%	0.00%	0.00%	0.00%	-91.07%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FEMY Femasys	2.50	Moderate Buy	$50.00	3,233.33% Upside
HSCS HeartSciences	2.00	Hold	$8.00	154.78% Upside
ICU SeaStar Medical	2.00	Hold	$8.00	231.95% Upside
ZYXI Zynex	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest ZYXI, HSCS, ICU, and FEMY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2026	ICU SeaStar Medical	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
9/21/2026	HSCS HeartSciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
8/18/2026	FEMY Femasys	Lake Street Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$10.00
8/17/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/14/2026	FEMY Femasys	Maxim Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$10.00
7/31/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 10/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FEMY Femasys	$2.29M	5.49	N/A	N/A	$2.01 per share	0.75
HSCS HeartSciences	N/A	N/A	N/A	N/A	$0.07 per share	N/A
ICU SeaStar Medical	$1.23M	8.64	N/A	N/A	$2.75 per share	0.88
ZYXI Zynex	$108.20M	0.04	$0.25 per share	0.51	$1.12 per share	0.11

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FEMY Femasys	-$18.63M	-$3.53	N/A	N/A	N/A	-534.36%	-225.97%	-74.68%	11/17/2026 (Estimated)
HSCS HeartSciences	-$9.14M	-$3.22	N/A	N/A	N/A	N/A	-816.90%	-181.97%	12/21/2026 (Estimated)
ICU SeaStar Medical	-$12.15M	-$3.91	N/A	N/A	N/A	-795.51%	-162.75%	-109.89%	11/12/2026 (Estimated)
ZYXI Zynex	$2.99M	-$2.43	N/A	0.27	N/A	-68.35%	-804.30%	-36.67%	N/A

Latest ZYXI, HSCS, ICU, and FEMY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/17/2026	Q3 2026	FEMY Femasys	-$0.47	N/A	N/A	N/A	$0.76 million	N/A
11/12/2026	Q3 2026	ICU SeaStar Medical	-$0.95	N/A	N/A	N/A	$0.50 million	N/A
9/14/2026	Q1 2027	HSCS HeartSciences	-$0.72	-$0.86	-$0.14	-$0.86	$0.10 million	$0.00 million
8/14/2026	Q2 2026	FEMY Femasys	-$1.31	-$1.33	-$0.02	-$1.33	$0.73 million	$0.33 million
8/12/2026	Q2 2026	ICU SeaStar Medical	-$0.97	-$0.91	+$0.06	-$0.91	$0.49 million	$0.62 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
FEMY Femasys	N/A	N/A	N/A	N/A	N/A
HSCS HeartSciences	N/A	N/A	N/A	N/A	N/A
ICU SeaStar Medical	N/A	N/A	N/A	N/A	N/A
ZYXI Zynex	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FEMY Femasys	0.89	2.14	0.55
HSCS HeartSciences	N/A	0.14	0.07
ICU SeaStar Medical	N/A	1.89	1.87
ZYXI Zynex	0.56	0.47	0.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FEMY Femasys	65.27%
HSCS HeartSciences	17.24%
ICU SeaStar Medical	1.69%
ZYXI Zynex	29.68%

Insider Ownership

Company	Insider Ownership
FEMY Femasys	7.75%
HSCS HeartSciences	4.90%
ICU SeaStar Medical	0.70%
ZYXI Zynex	49.28%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FEMY Femasys	54	8.38 million	7.73 million	Not Optionable
HSCS HeartSciences	14	4.97 million	4.73 million	Not Optionable
ICU SeaStar Medical	2	4.41 million	4.38 million	Not Optionable
ZYXI Zynex	770	30.39 million	15.41 million	No Data

ZYXI, HSCS, ICU, and FEMY Headlines

Recent News About These Companies

Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm

July 21, 2026 | prnewswire.com

Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm

July 13, 2026 | globenewswire.com

ZYXIQ CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

April 21, 2026 | newsfilecorp.comN

ZYXIQ INVESTOR ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zynex, Inc.

April 16, 2026 | globenewswire.com

ZYNEX LEAD PLAINTIFF DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Reminds Zynex, Inc Investors to Contact the Firm Before the April 21st Lead Plaintiff Deadline

April 13, 2026 | globenewswire.com

Levi & Korsinsky Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline â€“ ZYXIQ

April 13, 2026 | globenewswire.com

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Zynex, Inc. (ZYXIQ)

April 10, 2026 | globenewswire.com

ZYXIQ Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Zynex, Inc. Securities Class Action Lawsuit â€” The Gross Law Firm

April 10, 2026 | globenewswire.com

ZYXIQ EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

April 9, 2026 | newsfilecorp.comN

ZYXIQ INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Zynex Investors of Securities Class Action Deadline on April 21, 2026

April 3, 2026 | prnewswire.com

ZYXIQ UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

April 1, 2026 | globenewswire.com

Zynex, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 21, 2026 to Discuss Your Rights - ZYXIQ

April 1, 2026 | prnewswire.com

ZYXI SHAREHOLDER ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 30, 2026 | prnewswire.com

ZYXIQ Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zynex, Inc. Securities Lawsuit â€” The Gross Law Firm

March 27, 2026 | globenewswire.com

ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 24, 2026 | prnewswire.com

ZYXIQ CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

March 23, 2026 | newsfilecorp.comN

ZYXI ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 20, 2026 | prnewswire.com

ZYXI SHAREHOLDER NOTICE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 19, 2026 | globenewswire.com

Shareholders that lost money on Zynex, Inc. (ZYXIQ) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

March 18, 2026 | prnewswire.com

ZYXI INVESTOR ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 17, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ZYXI, HSCS, ICU, and FEMY Company Descriptions

Femasys NASDAQ:FEMY

$1.50 0.00 (0.00%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$1.53 +0.03 (+2.00%)

As of 04:07 AM Eastern

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

HeartSciences NASDAQ:HSCS

$3.14 0.00 (0.00%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$3.22 +0.07 (+2.39%)

As of 04:09 AM Eastern

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

SeaStar Medical NASDAQ:ICU

$2.41 0.00 (0.00%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$2.43 +0.02 (+0.83%)

As of 05:19 AM Eastern

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

Zynex NASDAQ:ZYXI

$0.12 0.00 (0.00%)

As of 10/23/2026

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZYXI, HSCS, ICU, and FEMY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZYXI, HSCS, ICU, and FEMY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZYXI, HSCS, ICU, and FEMY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ZYXI, HSCS, ICU, and FEMY Company Descriptions

Femasys NASDAQ:FEMY

HeartSciences NASDAQ:HSCS

SeaStar Medical NASDAQ:ICU

Zynex NASDAQ:ZYXI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZYXI, HSCS, ICU, and FEMY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZYXI, HSCS, ICU, and FEMY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZYXI, HSCS, ICU, and FEMY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ZYXI, HSCS, ICU, and FEMY Company Descriptions

Femasys NASDAQ:FEMY

HeartSciences NASDAQ:HSCS

SeaStar Medical NASDAQ:ICU

Zynex NASDAQ:ZYXI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools